Live TVMarketsFinanceEconomicsIndustriesTechReal EstateSmall BusinessPoliticsVideo
Top SecuritiesDOW (DIA) $522.57 ▼0.36%S&P 500 (SPY) $757.25 ▼0.34%NASDAQ 25,366 ▼0.39%10Y 5.10% ▲12 bpBITCOIN $69,007 ▼3.43%NASDAQ 100 (QQQ) $688.17 ▼0.32%30Y MORTGAGE 7.11% ▼0.07
Thursday, November 12, 2026 Edition · Raleigh 52° Mostly Clear Watch Live Sign in Subscribe
Genius Eye NewsA service of The GET Network, Inc.
Markets
Politics

Experts warn of blindness risk from widely prescribed GLP-1 drugs

The Hill reports concerns that rare side effects of GLP-1 medications could impact many due to their widespread use.

Nov 12, 2026, 10:36 AM By the Genius Eye newsroom (Politics Reporter) · Fact-checkedHow we report
Hugh Venables / CC BY-SA 2.0, via Wikimedia Commons

The Hill reported concerns about the risk of blindness associated with GLP-1 drugs, which are prescribed to millions of people.

Although the complication is uncommon, the large number of users means a significant number could be affected, according to The Hill.

The report highlights the importance of considering these risks when prescribing GLP-1 medications.

Medical professionals and patients are urged to be aware of potential side effects as the use of these drugs continues to grow.

Sources
  1. The Hill: The risk of blindness from GLP-1 drugs is too serious to ignore
We read public reporting and official data, confirm what we can, and write our own story. See something wrong? Request a correction.

Comments

No comments yet.

Sign in to comment